Pegol is a term used in generic names for pharmaceutical drugs to indicate the presence of a polyethylene glycol attachment (pegylation). The term is used for monoclonal antibodies and engineered proteins as well as for small molecules. The purpose of the pegylation is to extend the half-life of the drug.[1]
Examples include:
References
edit- ^ Swierczewska, Magdalena; Lee, Kang Choon; Lee, Seulki (2015). "What is the future of PEGylated therapies?". Expert Opinion on Emerging Drugs. 20 (4): 531–536. doi:10.1517/14728214.2015.1113254. PMC 4908577. PMID 26583759.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |